HELPING THE OTHERS REALIZE THE ADVANTAGES OF LINK ALTERNATIF MBL77

Are BTK and PLCG2 mutations vital and sufficient for ibrutinib resistance in Long-term lymphocytic leukemia?Persistent lymphocytic leukemia (CLL) is a lymphoid malignancy characterised because of the proliferation and accumulation of experienced CD5+ B cells inside the blood, bone marrow and lymphoid tissues. The prognosis of CLL calls for the pres